Filtered By:
Source: Journal of Vascular Surgery
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
PC050. Postapproval Safety and Efficacy of Transcarotid Arterial Revascularization
Transcarotid arterial revascularization (TCAR) is a hybrid, less invasive, technique for revascularization of high-risk patients using flow reversal for neuroprotection. The ROADSTER trial demonstrated safety and stroke risk reduction in a trial setting. The purpose of this study is to evaluate the outcomes of this technique in a real-world setting after Food and Drug Administration approval.
Source: Journal of Vascular Surgery - May 22, 2018 Category: Surgery Authors: Mark D. Balceniuk, Michael C. Stoner, Brian C. Ayers, Angela A. Kokkosis, Apostolos K. Tassiopoulos Source Type: research
